Jin G. Choi
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Molecular Insights into Parkinson's Disease Progression: A Multi-omics Analysis of the Substantia Nigra Pars Compacta across Braak Stages.
Journal: Experimental neurobiology
Published: December 08, 2025
De novo identification of potent ingredients for proteasome activation in MT101-5 using an AI-driven approach.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 11, 2025
Efficacy and Safety of MT104, A Dietary Supplement Based on Cuscuta Seeds and Heat-Killed Probiotics, on Cognitive Function in Patients with Mild Cognitive Impairment: A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Journal: Journal of medicinal food
Published: June 30, 2025
P. mirabilis-derived pore-forming haemolysin, HpmA drives intestinal alpha-synuclein aggregation in a mouse model of neurodegeneration.
Journal: EBioMedicine
Published: May 30, 2023
6-Shogaol, an Active Ingredient of Ginger, Improves Intestinal and Brain Abnormalities in Proteus Mirabilis-Induced Parkinson's Disease Mouse Model.
Journal: Biomolecules & therapeutics
Published: May 19, 2023
Peripheral metabolic alterations associated with pathological manifestations of Parkinson's disease in gut-brain axis-based mouse model.
Journal: Frontiers in molecular neuroscience
Published: April 06, 2023
Longan extract suppresses food intake through regulation of POMC/AgRP neuronal activities and endoplasmic reticulum stress in hypothalamus of db/db mice.
Journal: Frontiers in nutrition
Published: January 13, 2023
Protective effects of CCL01 against Aβ-induced neurotoxicity in 5xFAD transgenic mouse model of Alzheimer's disease.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 27, 2022
Aerial part of Houttuynia cordata reverses memory impairment by regulating amyloid beta accumulation and neuroinflammation in Alzheimer's disease model.
Journal: Phytotherapy research : PTR
Published: August 29, 2022
Inhibition of α-synuclein aggregation by MT101-5 is neuroprotective in mouse models of Parkinson's disease.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 13, 2022
DA-9805, a Herbal Mixture, Restores Motor Manifestations in 6-Hydroxydopamine-induced Parkinson's Disease Mouse Model by Regulating Striatal Dopamine and Acetylcholine Levels.
Journal: Frontiers in pharmacology
Published: March 24, 2022
Last Updated: 09/26/2026